Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts’ meeting on serum biomarkers

• Kirsten E. Wiens,

  Affiliation Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Barbara Jauregui,

  Affiliation Mérieux Foundation USA, Washington, District of Columbia, United States of America

  ⨯
• Benjamin F. Arnold,

  Affiliations Francis I. Proctor Foundation, University of California, San Francisco, California, United States of America, Department of Ophthalmology, University of California, San Francisco, California, United States of America

  ⨯
• Kathryn Banke,

  Affiliation Bill & Melinda Gates Foundation, Seattle, Washington, United States of America

  ⨯
• Djibril Wade,

  Affiliation Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formation (IRESSEF), Dakar, Senegal

  ⨯
• Kyla Hayford,

  Affiliation International vaccine access center (IVAC), Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America

  ⨯
• Adriana Costero-Saint Denis,

  Affiliation Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America

  ⨯
• Robert H. Hall,

  Affiliation Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States of America

  ⨯
• Henrik Salje,

  Affiliation Department of Genetics, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Isabel Rodriguez-Barraquer,

  Affiliations Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, California, United States of America, Division of Experimental Medicine, University of California, San Francisco, California, United States of America

  ⨯
• Andrew S. Azman,

  Affiliations Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America, Médecins Sans Frontières, Geneva, Switzerland, Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland

  ⨯
• Guy Vernet,

  Affiliations Mérieux Foundation USA, Washington, District of Columbia, United States of America, Institut Pasteur de Bangui, Bangui, Central African Republic

  ⨯
• Daniel T. Leung ,

  * E-mail: daniel.leung@utah.edu

  Affiliations Division of Infectious Diseases, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, United States of America, Division of Microbiology and Immunology, Department of Pathology, University of Utah, Salt Lake City, Utah, United States of America

  https://orcid.org/0000-0001-8401-0801

  ⨯
• on behalf of the Collaboration on Integrated Biomarkers Surveillance

  ¶Membership of the Collaboration on Integrated Biomarkers Surveillance is provided in Supporting Information file S1 Acknowledgments.

  ⨯